Search Results - "Braam, Pètra"

Parotid Gland Function After Radiotherapy: The Combined Michigan and Utrecht Experience by Dijkema, Tim, M.D, Raaijmakers, Cornelis P.J., Ph.D, Ten Haken, Randall K., Ph.D, Roesink, Judith M., M.D., Ph.D, Braam, Pètra M., M.D., Ph.D, Houweling, Anette C., M.Sc, Moerland, Marinus A., Ph.D, Eisbruch, Avraham, M.D, Terhaard, Chris H.J., M.D. Ph.D

“…Purpose To analyze the combined and updated results from the University of Michigan and University Medical Center Utrecht on normal tissue complication…”
Get full text

A moderate dose of preoperative radiotherapy may improve resectability in myxoid liposarcoma by Lansu, Jules, Braam, Pètra M., van Werkhoven, Erik, Scholten, Astrid N., Schrage, Yvonne, van Houdt, Winan J., van Langevelde, Kirsten, Haas, Rick L.

“…Histotype specific neoadjuvant therapy response data is scarce in soft tissue sarcomas. This study aimed to assess the impact of a moderate radiotherapy (RT)…”
Get full text

Transarterial Chemoembolization With Drug-Eluting Beads Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Outcomes From a Multicenter, Randomized, Phase 2 Trial (the TRENDY Trial) by Méndez Romero, Alejandra, van der Holt, Bronno, Willemssen, Francois E J A, de Man, Rob A, Heijmen, Ben J M, Habraken, Steven, Westerveld, Henrike, van Delden, Otto M, Klümpen, Heinz-Josef, Tjwa, Eric T T L, Braam, Pètra M, Jenniskens, Sjoerd F M, Vanwolleghem, Thomas, Weytjens, Reinhilde, d'Archambeau, Olivier, de Vos-Geelen, Judith, Buijsen, Jeroen, van der Leij, Christiaan, den Toom, Wilhelm, Sprengers, Dave, IJzermans, Jan N M, Moelker, Adriaan

“…To compare transarterial chemoembolization delivered with drug eluting beads (TACE-DEB) with stereotactioc body radiation therapy (SBRT) in patients with…”
Get full text

The Dutch–Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases by Méndez Romero, Alejandra, Schillemans, Wilco, van Os, Rob, Koppe, Friederike, Haasbeek, Cornelis J., Hendriksen, Ellen M., Muller, Karin, Ceha, Heleen M., Braam, Pètra M., Reerink, Onne, Intven, Martijn P.M., Joye, Ines, Jansen, Edwin P.M., Westerveld, Henrike, Koedijk, Merel S., Heijmen, Ben J.M., Buijsen, Jeroen

“…Although various studies have reported that stereotactic body radiation therapy (SBRT) for liver metastases has high local control rates and relatively low…”
Get full text

Primary sarcoma of the heart: case report and literature review by Moeri-Schimmel, Rieneke, Pras, Elisabeth, Desar, Ingrid, Krol, Stijn, Braam, Pètra

“…Primary cardiac tumors are extremely rare. Most primary cardiac tumors are benign and around one quarter is malign. Sarcomas are accounting for 95% of these…”
Get full text

Patient-reported outcomes after external beam radiotherapy versus brachytherapy for palliation of dysphagia in esophageal cancer: A matched comparison of two prospective trials by van Rossum, Peter S.N., Jeene, Paul M., Rozema, Tom, Braam, Pètra M., Lips, Irene M., Muller, Karin, van Kampen, Daphne, Vermeulen, Bram D., Homs, Marjolein Y.V., Oppedijk, Vera, Berbée, Maaike, Hulshof, Maarten C.C.M., Siersema, Peter D., El Sharouni, Sherif Y.

“…•Brachytherapy is an underused standard treatment for malignant dysphagia.•Short course external beam radiotherapy (EBRT) is an understudied alternative.•A…”
Get full text

Short-Course External Beam Radiotherapy Versus Brachytherapy for Palliation of Dysphagia in Esophageal Cancer: A Matched Comparison of Two Prospective Trials by Jeene, Paul M, Vermeulen, Bram D, Rozema, Tom, Braam, Pètra M, Lips, Irene, Muller, Karin, van Kampen, Daphne, Homs, Marjolein Y V, Oppedijk, Vera, Berbée, Maaike, van Rossum, Peter S N, El Sharouni, Sherif, Siersema, Peter D, Hulshof, Maarten C C M

“…Short-course external beam radiotherapy (EBRT) and intraluminal brachytherapy are both accepted treatments for the palliation of dysphagia in patients with…”
Get more information

Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort by Alongi, Filippo, Nicosia, Luca, Ricardi, Umberto, Scorsetti, Marta, Greto, Daniela, Balermpas, Panagiotis, Lievens, Yolande, Braam, Pètra, Jereczek-Fossa, Barbara Alicja, Stellamans, Karin, Ratosa, Ivica, Simek, Inga-Malin, Peulen, Heike, Dirix, Piet, Verbeke, Luc, Ramella, Sara, Hemmatazad, Hossein, Khanfir, Kaouthar, Geets, Xavier, Jeene, Paul, Zilli, Thomas, Fournier, Beatrice, Fortpied, Catherine, Boakye Oppong, Felix, Ost, Piet, Guckenberger, Matthias

“…•SBRT is commonly used for the treatment of oligometastatic disease.•Few large prospective data are available regarding SBRT-realted toxicity.•The present is a…”
Get full text

Overall Survival of Patients with Myxofibrosarcomas: An Epidemiological Study by van der Horst, Chiel A J, Bongers, Sabien L M, Versleijen-Jonkers, Yvonne M H, Ho, Vincent K Y, Braam, Pètra M, Flucke, Uta E, de Wilt, Johannes H W, Desar, Ingrid M E

“…Myxofibrosarcoma (MFS) is a rare mesenchymal soft tissue sarcoma type, with a high local recurrence (LR) rate. Robust epidemiological data on MFS are lacking…”
Get full text

Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study by Christ, Sebastian M., Alongi, Filippo, Ricardi, Umberto, Scorsetti, Marta, Livi, Lorenzo, Balermpas, Panagiotis, Lievens, Yolande, Braam, Pètra, Jereczek-Fossa, Barbara Alicja, Stellamans, Karin, Ratosa, Ivica, Widder, Joachim, Peulen, Heike, Dirix, Piet, Bral, Samuel, Ramella, Sara, Hemmatazad, Hossein, Khanfir, Kaouthar, Geets, Xavier, Jeene, Paul, Zilli, Thomas, Fournier, Beatrice, Ivaldi, Giovanni Battista, Clementel, Enrico, Fortpied, Catherine, Oppong, Felix Boakye, Ost, Piet, Guckenberger, Matthias

“…•Optimal dose and fractionation in SBRT for oligometastatic cancer patients remain unknown.•In the first 1,099 OligoCare patients, median number of fractions…”
Get full text

Small Cell Carcinoma of the Esophagus: A Nationwide Analysis of Treatment and Outcome at Patient Level in Locoregional Disease by Jeene, Paul M, Geijsen, Elisabeth D, Muijs, Christina T, Rozema, Tom, Aleman, Berthe M P, Muller, Karin, Baas, Jara M, Nuyttens, Joost J, Wouterse, Sanne, Braam, Pètra M, Oppedijk, Vera, Ceha, Heleen M, Cnossen, Jeltsje, Spruit, Patty, Bongers, Eva M, Berbée, Maaike, Mook, Stella, Hulshof, Maarten C C M

“…Small cell carcinoma of the esophagus (SCEC) is a rare subtype of esophageal cancer for which optimal treatment is unknown. We analyzed the impact of treatment…”
Get full text

Interobserver variation in tumor delineation of liver metastases using Magnetic Resonance Imaging by Peltenburg, Julia E., Hosni, Ali, Bahij, Rana, Boeke, Simon, Braam, Pètra M., Hall, William A., Intven, Martijn P.W., Nicosia, Luca, Sonke, Jan-Jakob, Witte, Marnix, Nowee, Marlies E., Janssen, Tomas

“…•Delineation variation in liver metastases on MRI was 1.6 mm standard deviation.•Delineation variation after peer review was reduced to 1.3 mm standard…”
Get full text

Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014 by Jeene, Paul M, de Vries, Kim C, van Nes, Johanna G H, Kwakman, Johannes J M, Wester, Gerda, Rozema, Tom, Braam, Pètra M, Zindler, Jaap D, Koper, Peter, Nuyttens, Joost J, Vos-Westerman, Hanneke A, Schmeets, Ilona, Niël, Charles G H J, Hutschemaekers, Stefan, van der Linden, Yvette M, Verhoeff, Joost J C, Stalpers, Lukas J A

“…Whole brain radiotherapy (WBRT) is considered standard of care for patients with multiple brain metastases or unfit for radical treatment modalities. Recent…”
Get more information

Large Cohort Dose–Volume Response Analysis of Parotid Gland Function After Radiotherapy: Intensity-Modulated Versus Conventional Radiotherapy by Dijkema, Tim, M.D, Terhaard, Chris H.J., M.D., Ph.D, Roesink, Judith M., M.D., Ph.D, Braam, Pètra M., M.D., Ph.D, van Gils, Carla H., Ph.D, Moerland, Marinus A., Ph.D, Raaijmakers, Cornelis P.J., Ph.D

“…Purpose To compare parotid gland dose–volume response relationships in a large cohort of patients treated with intensity-modulated (IMRT) and conventional…”
Get full text

Diagnosed with a Rare Cancer: Experiences of Adult Sarcoma Survivors with the Healthcare System-Results from the SURVSARC Study by Drabbe, Cas, Grünhagen, Dirk J, Van Houdt, Winan J, Braam, Pètra M, Soomers, Vicky L M N, Van der Hage, Jos A, De Haan, Jacco J, Keymeulen, Kristien B M I, Husson, Olga, Van der Graaf, Winette T A

“…The aim of this study was to explore the experience of rare cancer patients with the healthcare system and examine differences between age groups (adolescents…”
Get full text

The TRENDY multi-center randomized trial on hepatocellular carcinoma – Trial QA including automated treatment planning and benchmark-case results by Habraken, Steven J.M., Sharfo, Abdul Wahab M., Buijsen, Jeroen, Verbakel, Wilko F.A.R., Haasbeek, Cornelis J.A., Öllers, Michel C., Westerveld, Henrike, van Wieringen, Niek, Reerink, Onne, Seravalli, Enrica, Braam, Pètra M., Wendling, Markus, Lacornerie, Thomas, Mirabel, Xavier, Weytjens, Reinhilde, Depuydt, Lieselotte, Tanadini-Lang, Stephanie, Riesterer, Oliver, Haustermans, Karin, Depuydt, Tom, Dwarkasing, Roy S., Willemssen, François E.J.A., Heijmen, Ben J.M., Méndez Romero, Alejandra

“…The TRENDY trial is an international multi-center phase-II study, randomizing hepatocellular carcinoma (HCC) patients between transarterial chemoembolization…”
Get full text

Mesorectal shape variation in rectal cancer radiotherapy in prone position using a belly board by Cox, Maurice C., Braam, Pètra M., Rütten, Heidi, van Leeuwen, Ruud, Wendling, Markus

“…•Mesorectal shape variation is diverse and largest in the upper-anterior region.•Derived planning target volume margins for the upper-anterior region were…”
Get full text

Low-Dose Versus High-Dose Radiation Therapy for the Palliation of Dysphagia From Esophageal Cancer: A Multicenter Retrospective Cohort Study by Vermeulen, Bram D., Jeene, Paul M., Sijben, Jasmijn, Krol, Robin, Rütten, Heidi, Bogers, Johannes A., Braam, Pètra M., Siersema, Peter D.

“…Clinical evidence regarding optimal radiation dose for palliation of dysphagia from esophageal cancer is generally lacking. In an effort to investigate optimal…”
Get full text

Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial by Lansu, Jules, Bovée, Judith V M G, Braam, Pètra, van Boven, Hester, Flucke, Uta, Bonenkamp, Johannes J, Miah, Aisha B, Zaidi, Shane H, Thway, Khin, Bruland, Øyvind S, Baldini, Elizabeth H, Jebsen, Nina L, Scholten, Astrid N, van den Ende, Piet L A, Krol, Augustinus D G, Ubbels, Jan F, van der Hage, Jos A, van Werkhoven, Erik, Klomp, Houke M, van der Graaf, Winette T A, van Coevorden, Frits, Schrage, Yvonne, van Houdt, Winan J, Haas, Rick L

“…Currently, preoperative radiotherapy for all soft-tissue sarcomas is identical at a 50-Gy dose level, which can be associated with morbidity, particularly…”
Get more information

The Prognostic Relevance of MRI Characteristics in Myxofibrosarcoma Patients Treated with Neoadjuvant Radiotherapy by van Ravensteijn, Stefan G, Nederkoorn, Maikel J L, Wal, Tom C P, Versleijen-Jonkers, Yvonne M H, Braam, Pètra M, Flucke, Uta E, Bonenkamp, Johannes J, Schreuder, Bart H W, van Herpen, Carla M L, de Wilt, Johannes H W, Desar, Ingrid M E, de Rooy, Jacky W J

“…To improve local control, neoadjuvant radiotherapy (nRT) followed by surgery is the standard of care in myxofibrosarcoma (MFS) because of its infiltrative…”
Get full text